Stock listing
Lang & Schwarz:A14NY2 Sprint Bioscience AB Aktie
German listing (Lang & Schwarz) of Sprint Bioscience AB · home listing Stockholm:SPRINT
Follow Sprint Bioscience AB into a list and get an email when it puts out news.
Home listing price · OMXSTO:SPRINT
3.60 SEK +0.10 (+2.9%)
Close on Oct 30, 2026 · This listing has no price on 6ix; the price shown is the home listing's, OMXSTO:SPRINT
- Day range
- 3.51 – 3.63 SEKOct 30, 2026
- Volume
- 16,849 sharesOct 30, 2026
- Market cap
- 379.9M SEKAt the close on Oct 30, 2026 · price × 105.5M shares outstanding
- 52-week range
- 0.578 – 4.59 SEKLowest and highest trades, Oct 31, 2025 – Oct 30, 2026
- Traded on an average day
- 881,704 SEKMedian day 207,045 shares · last 3 months, Jul 30, 2026 – Oct 30, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| Stockholm:SPRINT · Home | 3.60 SEK | +0.10 (+2.9%) | 16,849 | 3.63 | 3.63 | 3.51 | 3.50 | Close on Oct 30, 2026 |
| Munich:5JA1 | €0.307 EUR | -0.012 (-3.8%) | — | €0.307 | €0.307 | €0.307 | €0.319 | Close on Oct 27, 2026 |
| Frankfurt:5JA1 | €0.308 EUR | +0.018 (+6.2%) | — | €0.298 | €0.308 | €0.298 | €0.290 | Close on Oct 30, 2026 |
Daily closes
Last 3 months, Jul 30, 2026 – Oct 30, 2026 · OMXSTO:SPRINT · SEK, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| 3.60 | +0.10 | +2.9% | 3.63 | 3.63 | 3.51 | 16,849 | |
| 3.50 | +0.06 | +1.7% | 3.41 | 3.70 | 3.41 | 290,890 | |
| 3.44 | +0.03 | +0.9% | 3.42 | 3.51 | 3.41 | 85,768 | |
| 3.41 | -0.04 | -1.2% | 3.45 | 3.45 | 3.33 | 102,608 | |
| 3.45 | +0.11 | +3.3% | 3.28 | 3.46 | 3.28 | 227,690 | |
| 3.34 | -0.01 | -0.3% | 3.35 | 3.39 | 3.25 | 49,508 | |
| 3.35 | -0.25 | -6.9% | 3.57 | 3.57 | 3.25 | 445,818 | |
| 3.60 | +0.14 | +4.0% | 3.52 | 3.63 | 3.50 | 61,451 | |
| 3.46 | -0.08 | -2.3% | 3.47 | 3.62 | 3.46 | 41,370 | |
| 3.54 | -0.01 | -0.3% | 3.52 | 3.62 | 3.43 | 303,932 | |
| 3.55 | -0.06 | -1.7% | 3.53 | 3.73 | 3.53 | 119,371 | |
| 3.61 | -0.22 | -5.7% | 3.75 | 3.76 | 3.52 | 228,072 | |
| 3.83 | +0.01 | +0.3% | 3.82 | 3.88 | 3.71 | 57,904 | |
| 3.82 | +0.07 | +1.9% | 3.72 | 3.88 | 3.67 | 341,205 | |
| 3.75 | +0.10 | +2.7% | 3.63 | 3.80 | 3.62 | 223,947 | |
| 3.65 | +0.01 | +0.3% | 3.59 | 3.72 | 3.56 | 392,328 | |
| 3.64 | +0.15 | +4.3% | 3.48 | 3.66 | 3.35 | 429,220 | |
| 3.49 | +0.03 | +0.9% | 3.46 | 3.62 | 3.37 | 188,324 | |
| 3.46 | -0.12 | -3.4% | 3.57 | 3.67 | 3.46 | 123,177 | |
| 3.58 | +0.05 | +1.4% | 3.56 | 3.65 | 3.40 | 207,045 | |
| 3.53 | -0.04 | -1.1% | 3.46 | 3.57 | 3.40 | 163,366 | |
| 3.57 | +0.17 | +5.0% | 3.41 | 3.57 | 3.40 | 577,486 | |
| 3.40 | +0.10 | +3.0% | 3.32 | 3.45 | 3.25 | 447,904 | |
| 3.30 | +0.18 | +5.8% | 3.09 | 3.33 | 3.09 | 574,593 | |
| 3.12 | +0.07 | +2.3% | 3.00 | 3.20 | 2.96 | 141,219 | |
| 3.05 | +0.27 | +9.7% | 2.80 | 3.17 | 2.79 | 241,509 | |
| 2.78 | +0.01 | +0.4% | 2.71 | 2.79 | 2.65 | 82,859 | |
| 2.77 | -0.08 | -2.8% | 2.80 | 2.86 | 2.55 | 115,101 | |
| 2.85 | -0.01 | -0.3% | 2.86 | 2.86 | 2.76 | 89,436 | |
| 2.86 | -0.09 | -3.1% | 2.95 | 2.98 | 2.81 | 90,099 | |
| 2.95 | 0.00 | 0.0% | 2.95 | 2.96 | 2.79 | 302,696 | |
| 2.95 | +0.05 | +1.7% | 2.84 | 2.96 | 2.75 | 363,948 | |
| 2.90 | +0.12 | +4.3% | 2.80 | 2.95 | 2.72 | 372,499 | |
| 2.78 | +0.04 | +1.5% | 2.74 | 2.82 | 2.71 | 83,496 | |
| 2.74 | 0.00 | 0.0% | 2.69 | 2.84 | 2.64 | 153,490 | |
| 2.74 | 0.00 | 0.0% | 2.72 | 2.74 | 2.55 | 1,252,178 | |
| 2.74 | -0.14 | -4.9% | 2.91 | 3.00 | 2.68 | 799,244 | |
| 2.88 | -0.31 | -9.7% | 3.13 | 3.14 | 2.84 | 891,948 | |
| 3.19 | -0.05 | -1.5% | 3.20 | 3.20 | 3.13 | 55,563 | |
| 3.24 | -0.01 | -0.3% | 3.26 | 3.27 | 3.13 | 127,187 | |
| 3.25 | -0.04 | -1.2% | 3.25 | 3.26 | 3.13 | 173,438 | |
| 3.29 | +0.01 | +0.3% | 3.22 | 3.35 | 3.22 | 110,005 | |
| 3.28 | -0.02 | -0.6% | 3.30 | 3.38 | 3.19 | 312,923 | |
| 3.30 | +0.10 | +3.1% | 3.12 | 3.30 | 3.10 | 268,442 | |
| 3.20 | +0.02 | +0.6% | 3.12 | 3.28 | 3.10 | 178,120 | |
| 3.18 | -0.11 | -3.3% | 3.22 | 3.28 | 3.08 | 343,872 | |
| 3.29 | +0.08 | +2.5% | 3.16 | 3.33 | 3.10 | 365,085 | |
| 3.21 | +0.06 | +1.9% | 3.00 | 3.23 | 2.98 | 313,756 | |
| 3.15 | 0.00 | 0.0% | 3.16 | 3.17 | 3.00 | 113,979 | |
| 3.15 | -0.02 | -0.6% | 3.17 | 3.21 | 3.00 | 375,413 | |
| 3.17 | +0.16 | +5.3% | 3.08 | 3.18 | 2.98 | 344,519 | |
| 3.01 | -0.28 | -8.5% | 3.26 | 3.36 | 2.77 | 1,367,233 | |
| 3.29 | -0.02 | -0.6% | 3.30 | 3.47 | 3.27 | 122,031 | |
| 3.31 | -0.06 | -1.8% | 3.37 | 3.37 | 3.25 | 66,233 | |
| 3.37 | +0.04 | +1.2% | 3.38 | 3.40 | 3.28 | 125,349 | |
| 3.33 | -0.08 | -2.3% | 3.33 | 3.49 | 3.33 | 129,008 | |
| 3.41 | +0.18 | +5.6% | 3.25 | 3.46 | 3.25 | 294,484 | |
| 3.23 | -0.13 | -3.9% | 3.37 | 3.44 | 3.23 | 526,107 | |
| 3.36 | -0.08 | -2.3% | 3.46 | 3.52 | 3.29 | 149,248 | |
| 3.44 | -0.06 | -1.7% | 3.51 | 3.59 | 3.40 | 92,828 | |
| 3.50 | +0.08 | +2.3% | 3.43 | 3.51 | 3.21 | 332,407 | |
| 3.42 | -0.06 | -1.7% | 3.50 | 3.55 | 3.36 | 156,096 | |
| 3.48 | -0.12 | -3.3% | 3.60 | 3.67 | 3.45 | 170,603 | |
| 3.60 | -0.02 | -0.6% | 3.63 | 3.71 | 3.52 | 275,058 | |
| 3.62 | +0.02 | +0.6% | 3.64 | 3.69 | 3.58 | 41,907 | |
| 3.60 | -0.13 | -3.5% | 3.74 | 3.79 | 3.52 | 243,702 | |
| 3.73 | +0.01 | +0.3% | 3.70 | 3.79 | 3.61 | 400,504 |
- Ticker
- Lang & Schwarz:A14NY2
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- Lang & Schwarz
- Currency
- EUR
What changed lately
Latest news release · Jul 23, 2026
Sprint Bioscience announces agreement with Lilly TuneLab to accelerate drug development
Latest news
Sprint Bioscience announces agreement with Lilly TuneLab to accelerate drug development
Jul 23, 2026
Closed 3.75 (+4.7%) on Jul 23, 2026
Sprint Bioscience (publ) announces that Aktiespararna initiates commissioned research coverage of the company
Jun 4, 2026
Closed 3.31 (-5.4%) on Jun 4, 2026
Sprint Bioscience completes strategic STK25 evaluation; continued focus on the primary indication
Apr 16, 2026
Closed 3.29 (-15.0%) on Apr 16, 2026
Sprint Bioscience appoints Jenni Björnulfson as CFO
Apr 1, 2026
Closed 2.60 (+9.2%) on Apr 1, 2026
Sprint Bioscience sells the TREX1 program to Gilead
Nov 24, 2025
Closed 1.44 (+116.2%) on Nov 24, 2025
Decks
Fact Sheet (April 2025)
Fact sheet · 7 slides · Apr 24, 2025
Sprint Bioscience AB on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 5 in the last 12 months · 5 in all · newest Jul 23, 2026 · oldest 2025
- Decks
- 1 deck · latest Apr 24, 2025
Where Sprint Bioscience AB is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| Stockholm:SPRINT · Home listing | Stockholm | Sweden | SEK |
| gettex:5JA1 | gettex | Germany | EUR |
| LS Exchange:A14NY2 | LS Exchange | Germany | EUR |
| Lang & Schwarz:A14NY2 · This page | Lang & Schwarz | Germany | EUR |
| Munich:5JA1 | Munich | Germany | EUR |
| Frankfurt:5JA1 | Frankfurt | Germany | EUR |
| Stuttgart:5JA1 | Stuttgart | Germany | EUR |
Log in to ask 6ix AI your own questions about Sprint Bioscience AB.